Arkolith/Insider Trading/TMDX/Form 4

Khayal Tamer I

Chief Commercial OfficerTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Nov 13, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$131K
Net Open-Market Flow
-$131K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 11, 2024Sell(S)1K$90.04$131K21K
Nov 11, 2024Option exercise(M)1K$38.46$56K22K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 11, 2024Option exercise(M)1K—$06K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-126397) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML